Rameswari Chilamakuri

Repurposing clofazimine for malignant pleural mesothelioma treatment - In-vitro assessment of efficacy and mechanism of action.

N. Kulkarni, Xuechun Wang, Vineela Parvathaneni, 2022, Life sciences.

Direct Targeting of the Raf-MEK-ERK Signaling Cascade Inhibits Neuroblastoma Growth

Rameswari Chilamakuri, Saurabh Agarwal, 2022, Current oncology.

Dual Targeting of PI3K and HDAC by CUDC-907 Inhibits Pediatric Neuroblastoma Growth

S. Agarwal, Rameswari Chilamakuri, 2022, Cancers.

Exploring Amodiaquine’s Repurposing Potential in Breast Cancer Treatment—Assessment of In-Vitro Efficacy & Mechanism of Action

N. Kulkarni, Vineela Parvathaneni, V MNSSVKR GUPTA, 2022, International journal of molecular sciences.

COVID-19: Characteristics and Therapeutics

S. Agarwal, Rameswari Chilamakuri, 2021, Cells.

BX-795 inhibits neuroblastoma growth and enhances sensitivity towards chemotherapy

Yang Yu, Jianhua Yang, A. Muth, 2021, Translational oncology.

Inhibition of Polo-like Kinase 1 by HMN-214 Blocks Cell Cycle Progression and Inhibits Neuroblastoma Growth

Rameswari Chilamakuri, Saurabh Agarwal, Danielle C. Rouse, 2022, Pharmaceuticals.